Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Charles A Stiller"'
Autor:
Fahmina Fardus-Reid, Lorna A Fern, Kathy Pritchard-Jones, Alison Cameron, Martin G. McCabe, Richard G. Feltbower, Lucy Irvine, Lucy Elliss-Brookes, Jon Shelton, Charles A. Stiller, Jess Fraser
Publikováno v:
Fraser, J, Fardus-Reid, F, Irvine, L, Elliss-Brookes, L, Fern, L, Cameron, A L, Pritchard-Jones, K, Feltbower, R G, Shelton, J, Stiller, C & McCabe, M G 2021, ' Oral etoposide as a single agent in childhood and young adult cancer in England : Still a poorly evaluated palliative treatment ', Pediatric Blood & Cancer, pp. e29204 . https://doi.org/10.1002/pbc.29204
BACKGROUND: Oral etoposide is commonly used in palliative treatment of childhood and young adult cancer without robust evidence. We describe a national, unselected cohort of young people in England treated with oral etoposide using routinely collecte
Autor:
Roddy O'Kane, Tom Kenny, Charles A. Stiller, Roger C Parslow, Ryan K. Mathew, Paul Chumas, Susan Picton
Publikováno v:
Neuro-Oncology. 16:1137-1145
We report a population-based study examining long-term outcomes for common pediatric CNS tumors comparing results from the UK with the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) data set and with the literature. No
Publikováno v:
The Lancet Oncology. 14:e329-e336
Extracranial rhabdoid tumours are rare, and often occur in infants. Although the kidney is the most common site, they can occur anywhere in the body. Most contain a biallelic inactivating mutation in SMARCB1, which is part of the chromatin remodellin
Autor:
Helen Jenkinson, Henry B Marsden, Michael C. Stevens, Michael M. Hawkins, Marilyn Stovall, D.L. Winter, Charles A. Stiller
Publikováno v:
British Journal of Cancer
Among 16 541 3-year survivors of childhood cancer in Britain, 39 soft tissue sarcomas (STSs) occurred and 1.1 sarcomas were expected, yielding a standardised incidence ratio (SIR) of 16.1. When retinoblastomas were excluded from the cohort, the SIR f
Autor:
Huib N. Caron, Gill Levitt, Bradley R. Pieters, Carol Mason, Martha A. Grootenhuis, David Dunaway, Mark N. Gaze, Raquel Dávila Fajardo, Jennifer E. Gains, Ludi E. Smeele, Cécile M. Ronckers, Aeilko H. Zwinderman, Christopher Abela, Reineke A. Schoot, Julia C. Chisholm, Leontien C. M. Kremer, Simon D. Strackee, Michiel W. M. van den Brekel, Olga Slater, Charles A. Stiller, Sanjeev Gupta, Henry Mandeville, Peter Hammond, Yen-Ching Chang, Eva Gajdosova, Johannes H. M. Merks, Heleen Maurice-Stam, Peerooz Saeed, Alfons J. M. Balm, Benjamin Hartley
Publikováno v:
European Journal of Cancer, 51(11), 1424-1434. Elsevier
European journal of cancer (Oxford, England, 51(11), 1424-1434. Elsevier Limited
Schoot, R A, Slater, O, Ronckers, C M, Zwinderman, A H, Balm, A J M, Hartley, B, van den Brekel, M W, Gupta, S, Saeed, P, Gajdosova, E, Pieters, B R, Gaze, M N, Mandeville, H C, Davila Fajardo, R, Chang, Y C, Gains, J E, Strackee, S D, Dunaway, D, Abela, C, Mason, C, Smeele, L E, Chisholm, J C, Levitt, G A, Kremer, L C M, Grootenhuis, M A, Maurice-Stam, H, Stiller, C A, Hammond, P, Caron, H N & Merks, J H M 2015, ' Adverse events of local treatment in long term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment ', European Journal of Cancer, vol. 51, no. 11, pp. 1424-1434 . https://doi.org/10.1016/j.ejca.2015.02.010
European Journal of Cancer, 51(11), 1424-1434. Elsevier Limited
European journal of cancer (Oxford, England, 51(11), 1424-1434. Elsevier Limited
Schoot, R A, Slater, O, Ronckers, C M, Zwinderman, A H, Balm, A J M, Hartley, B, van den Brekel, M W, Gupta, S, Saeed, P, Gajdosova, E, Pieters, B R, Gaze, M N, Mandeville, H C, Davila Fajardo, R, Chang, Y C, Gains, J E, Strackee, S D, Dunaway, D, Abela, C, Mason, C, Smeele, L E, Chisholm, J C, Levitt, G A, Kremer, L C M, Grootenhuis, M A, Maurice-Stam, H, Stiller, C A, Hammond, P, Caron, H N & Merks, J H M 2015, ' Adverse events of local treatment in long term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment ', European Journal of Cancer, vol. 51, no. 11, pp. 1424-1434 . https://doi.org/10.1016/j.ejca.2015.02.010
European Journal of Cancer, 51(11), 1424-1434. Elsevier Limited
BackgroundRadiotherapy is a well-known cause of adverse events (AEs). To reduce AEs, an innovative local treatment was developed in Amsterdam: Ablative surgery, MOuld brachytherapy and surgical REconstruction (AMORE).Aims: (1) to determine the preval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7421f6c1c80a5aa4d6b6ce1b479554e4
https://dare.uva.nl/personal/pure/en/publications/adverse-events-of-local-treatment-in-long-term-head-and-neck-rhabdomyosarcoma-survivors-after-external-beam-radiotherapy-or-amore-treatment(42931771-0fd1-48e1-9ade-ef4db61abcef).html
https://dare.uva.nl/personal/pure/en/publications/adverse-events-of-local-treatment-in-long-term-head-and-neck-rhabdomyosarcoma-survivors-after-external-beam-radiotherapy-or-amore-treatment(42931771-0fd1-48e1-9ade-ef4db61abcef).html
Autor:
Sanjay Tewari, Charles A. Stiller, Komel Khabra, Mary Taj, Donna Lancaster, Parameswaran Anoop, Sushama Sankpal
Publikováno v:
Leukemialymphoma. 53(10)
Patients with childhood relapsed and refractory mature B-cell non-Hodgkin lymphoma (B-NHL) and acute lymphoblastic leukemia (B-ALL) are rare and have a dismal prognosis. The previous UK national analysis of 26 children over a 7-year period prior to 1
Autor:
Elaine Sugden, Charles A. Stiller, Michael M. Hawkins, Aliki J. Taylor, David L. Winter, Marilyn Stovall, Clare Frobisher, David W. Ellison, Mark P. Little, Emma R Lancashire, Raoul C. Reulen
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(36)
Purpose CNS tumors are the most common second primary neoplasm (SPN) observed after childhood cancer in Britain, but the relationship of risk to doses of previous radiotherapy and chemotherapy is uncertain. Methods The British Childhood Cancer Surviv
Autor:
Charles A. Stiller, Debra L. Friedman, Norman E. Breslow, Joseph P. Neglia, Jane M. Lange, Jørgen H. Olsen, Michael F.G. Murphy, Daniel M. Green, Leslie L. Robison, Susan M. Peterson, Michael M. Hawkins
Publikováno v:
International journal of cancer. 127(3)
A combined cohort of 8,884 North American, 2,893 British and 1,574 Nordic subjects with Wilms tumor (WT) diagnosed before 15 years of age during 1960–2004 was established to determine the risk of secondary malignant neoplasms (SMN). After 169,641 p
Publikováno v:
Journal of Epidemiology and Community Health. 64(7)
Background: Children with Down's syndrome (DS) who developed leukaemia have had a worse prognosis than other children with leukaemia in the past. In the 1970s and early 1980s, some children with DS who developed leukaemia received fewer cycles of che
Publikováno v:
Archives of Disease in Childhood. 65:212-216
The outcome in children with acute leukaemia with (n = 90) and without Down's syndrome (n = 4377) was compared. Sixty three (70%) of those with Down's syndrome had acute lymphoblastic leukaemia and in comparison with 3664 (84%) controls had similar p